Hedge Funds Are Crazy About Sarepta Therapeutics Inc (SRPT)

As aggregate interest increased, key money managers were leading the bulls’ herd. Tourbillon Capital Partners, led by Jason Karp, assembled the most outsized position in Sarepta Therapeutics Inc (NASDAQ:SRPT). Tourbillon Capital Partners had $105.2 million invested in the company at the end of the quarter. Jeremy Green’s Redmile Group also made a $39.3 million investment in the stock during the quarter. The following funds were also among the new SRPT investors: Samuel Isaly’s OrbiMed Advisors, and Paul Tudor Jones’s Tudor Investment Corp.

Let’s now review hedge fund activity in other stocks similar to Sarepta Therapeutics Inc (NASDAQ:SRPT). These stocks are Air Lease Corp (NYSE:AL), Vector Group Ltd (NYSE:VGR), Masimo Corporation (NASDAQ:MASI), and Home Bancshares Inc (NASDAQ:HOMB). All of these stocks’ market caps are similar to SRPT’s market cap.

Ticker No of HFs with positions Total Value of HF Positions (x1000) Change in HF Position
AL 29 286070 0
VGR 10 164504 -5
MASI 26 163915 0
HOMB 9 32112 -4

As you can see these stocks had an average of 19 hedge funds with bullish positions and the average amount invested in these stocks was $162 million. That figure was $1.12 billion in SRPT’s case. Air Lease Corp (NYSE:AL) is the most popular stock in this table. On the other hand Home Bancshares Inc (NASDAQ:HOMB) is the least popular one with only 9 bullish hedge fund positions. Compared to these stocks Sarepta Therapeutics Inc (NASDAQ:SRPT) is more popular among hedge funds. Considering that hedge funds are fond of this stock in relation to its market cap peers, it may be a good idea to analyze it in detail and potentially include it in your portfolio.

Disclosure: None